EVE Health Sets November 2026 AGM as It Advances Vertically Integrated Pharma Platform tipranks.com
Transdermal MHT a potentially safer alternative to oral options Medical Republic
Transdermal MHT a potentially safer alternative to oral options medicalrepublic.com.au
Myfembree, a fixed-dose combination of relugolix, estradiol, and norethindrone acetate, is approved for premenopausal women with heavy menstrual bleeding associated with uterine fibroids and moderate to severe pain associated with …
A woman in her 20s presented with severe progressive dysmenorrhoea that began within 1-2 years of menarche, was refractory to medical therapy and required repeated emergency department visits for parenteral …
Women with endometriosis often face difficulty becoming pregnant, mainly when their ovaries produce only a small number of eggs. In assisted fertility treatments, hormones are used to help eggs mature …
Submucosal pseudoaneurysms located within the uterine wall can be particularly challenging to diagnose due to their atypical location and nonspecific clinical presentation. We report the case of a 32-year-old woman …
Female fertility has long been explained through observation of the ovarian follicle: the number of residing follicles and the quality of the oocyte. This review argues that the tissue surrounding …
This report explores the case of a young, normal-responder nulligravida with peritoneal endometriosis and recurrent implantation failure, with poor embryo quality during multiple failed attempts at IVF treatment. The patient …
Endometriosis relief? New non-hormonal drug targets lesions directly The Indian Express